Riskpilot← Back to searchSign inGet full accessNORVIA AB
ABActiveOrg 5566311428Armégatan 29General medical practice activities · NACE 8621Est. 20021-4 employees
Revenue 2024
SEK 3,8M
-11% vs 2023
EBITDA margin
15.6%
+992% vs 2023
Equity ratio
53.0%
Financial strength
Net profit 2024
SEK 930K
+777% vs 2023
| Revenue | SEK 3,8M | -11% |
| EBITDA | SEK 589K | +992% |
| Net profit | SEK 930K | +777% |
| Total assets | SEK 6,5M | -7% |
| Equity | SEK 3,5M | +27% |
| Employees | — | — |
Legal name
NORVIA AB
Org number
5566311428
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
9 oktober 2002
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet är läkarverksamhet, allmän läkarpraktik och akutbehandlingar, läkarmottagning och hembesök, företagshälsovård, äga och förvalta fastigheter och värdepapper, import och försäljning av electromedicinsk utrustning samt därmed förenlig verksamhet.
Address
Armégatan 29
Phone
+46707606081
Email
info@ebide.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 622 | 4 588 | 4 245 | 4 259 | 3 770 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 797 | 2 605 | 451 | −66 | 589 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 797 | 2 605 | 451 | −66 | 589 |
| Net financials | −1 | −3 | −1 | 20 | 1 |
| Profit before tax | 517 | 2 438 | 502 | 191 | 930 |
| Tax | −180 | −209 | −147 | −85 | −0 |
| Net profit | 337 | 2 229 | 355 | 106 | 930 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 796 | 7 049 | 7 090 | 7 054 | 6 530 |
| Equity | 1 839 | 3 268 | 3 123 | 2 729 | 3 459 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 210 | 326 | 420 | 871 | 1 204 |
| Total debt | 210 | 326 | 420 | 871 | 1 204 |
EBITDA margin
15.6%
This company
15.8%
Market median
+1% vs market
20202024
Equity ratio
53.0%
This company
38.2%
Market median
+39% vs market
20202024
Return on equity
26.9%
This company
18.4%
Market median
+46% vs market
20202024
Net profit margin
24.7%
This company
8.1%
Market median
+205% vs market
20202024
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20202024
Debt / equity
0.89×
This company
0.62×
Market median
+44% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JI | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORVIA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Ingemar Gustafsson | Audit | 0 companies |
| Fatemeh Norouzi | Deputy Board Member | 0 companies |
| Faramarz Norouzi | Board of Directors | 0 companies |
| Faramarz Norouzi | Deputy Board Member | 0 companies |